Targeting protein BCL-2 may create a promising pathway to reversing pulmonary fibrosis

Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent pulmonary fibrosis and identified a promising strategy to reverse it. The recent study published in Nature Communications reveals that the protein BCL-2 impedes normal lung repair and that targeting it may restore lung health.